1-3 of 3
Hui Yang, PhD
Close
Sort by
Journal Articles

A Phase II Study of Nivolumab or Ipilimumab with or without Azacitidine for Patients with Myelodysplastic Syndrome (MDS)

Guillermo Garcia-Manero, MD, Koji Sasaki, MD, Guillermo Montalban-Bravo, MD, Naval G. Daver, MD, Elias J. Jabbour, MD, Yesid Alvarado, MD, Courtney D. DiNardo, MD, MSc, Farhad Ravandi, MD, Gautam Borthakur, MD, Prithviraj Bose, MD, Naveen Pemmaraju, MD, Kiran Naqvi, MD, MPH, Jorge E. Cortes, MD, Tapan M. Kadia, MD, Marina Y. Konopleva, MD, PhD, Simona Colla, PhD, Hui Yang, PhD, MD, Caitlin R. Rausch, PharmD, Yvonne Gasior, RN, Carlos E. Bueso-Ramos, MD, PhD, Rashmi Kanagal-Shamanna, MD, Keyur P. Patel, MBBS, PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 465.
https://doi.org/10.1182/blood-2018-99-119424
Published: 2018
Journal Articles

Gain-of-Function of ASXL1 Truncating Protein in the Pathogenesis of Myeloid Malignancies

Hui Yang, PhD, Stefan Kurtenbach, PhD, Ying Guo, MD PhD, Ines Lohse, PhD, Michael Durante, PhD candidate, Peng Zhang, PhD, Yuan Zhou, PhD, William Harbour, MDPhD, Claes Wahlestedt, Mingjiang Xu, MDPhD, Feng-Chun Yang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 564.
https://doi.org/10.1182/blood.V130.Suppl_1.564.564
Published: 2017
Journal Articles

Inhibition of T Cell Proliferation By Granulocyte Membrane-Associated Proteinase 3 Is Reversed By Blocking the Interaction of Calreticulin with LRP on T Cells

Tian-Hui Yang, PhD, Lisa S. St. John, PhD, Karen Clise-Dwyer, PhD, Kathryn Ruisaard, MS, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD
Journal: Blood
Blood (2014) 124 (21): 4110.
https://doi.org/10.1182/blood.V124.21.4110.4110
Published: 2014